DENTSPLY SIRONA Inc.

For the period ended Jun 30, 2025. Filed Aug 7, 2025.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2025 · Filed Aug 7, 2025

XRAY$9.54+0.8%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Statements of Operations

(in millions, except per share amounts)

	Three Months Ended June 30,		Six Months Ended June 30,
	2025	2024	2025	2024
Net sales	$936	$984	$1,815	$1,937
Cost of products sold	446	473	859	920
Gross profit	490	511	956	1,017
Selling, general, and administrative expenses	342	399	700	814
Research and development expenses	37	41	73	83
Goodwill and intangible asset impairments	235	—	235	6
Restructuring and other costs	4	21	13	22
Operating (loss) income	(128)	50	(65)	92
Other income and expenses:
Interest expense, net	24	17	43	35
Other expense (income), net	1	(1)	1	(8)
(Loss) income before income taxes	(153)	34	(109)	65
(Benefit) provision for income taxes	(109)	38	(84)	52
Net (loss) income	(44)	(4)	(25)	13
Less: Net income (loss) attributable to noncontrolling interest	1	—	—	(1)
Net (loss) income attributable to Dentsply Sirona	$(45)	$(4)	$(25)	$14
(Loss) earnings per common share attributable to Dentsply Sirona:
Basic	$(0.22)	$(0.02)	$(0.13)	$0.07
Diluted	$(0.22)	$(0.02)	$(0.13)	$0.07
Weighted average common shares outstanding:
Basic	199.3	205.6	199.2	206.5
Diluted	199.3	205.6	199.2	207.3

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.